Perspective Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Perspective Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2013 to Q4 2023.
  • Perspective Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2023 was -$59.9K.
  • Perspective Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2023 was $84.000.
  • Perspective Therapeutics, Inc. annual Interest Expense for 2023 was $84.000.
  • Perspective Therapeutics, Inc. annual Interest Expense for 2022 was $0.000.
  • Perspective Therapeutics, Inc. annual Interest Expense for 2017 was $0.000, a 100% decline from 2016.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $84.00 -$59.9K -$59.9K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $60K $14K +$14K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $46K $28K +$28K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $18K $18K +$18K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q2 2016 $1K $50.00 +$1.6K Apr 1, 2016 Jun 30, 2016 10-K 2018-09-26
Q1 2016 -$601 $0 -$100 -100% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 -$501 $0 $0 Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-09
Q3 2015 -$501 $950 -$2.5K -72.5% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $2K -$1.55K Apr 1, 2015 Jun 30, 2015 10-K 2017-09-28
Q1 2015 $100 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $0 -$86 -100% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $3.45K +$2.71K +366% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q4 2013 $86.00 Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $741 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.